Alnylam announces that the United Kingdom’s MHRA grants early access to lumasiran

13 July 2020 - Positive scientific opinion under Early Access to Medicines Scheme will make lumasiran treatment available for UK primary ...

Read more →

Six months into the pandemic, how much closer are we to a vaccine?

13 July 2020 - Queensland scientists racing to make a COVID-19 vaccine are upbeat as their research begins critical human ...

Read more →

Are high‐cost drug funding mechanisms fit for purpose? A retrospective study of individual funding requests in an NHS tertiary hospital

13 July 2020 - This paper reports on a retrospective study of individual funding request submissions from a large tertiary hospital ...

Read more →

Collaborative consultation on medicines policy closes

10 July 2020 - Over the past few months, Medicines New Zealand ran an online consultation on a discussion paper produced ...

Read more →

Drugmakers appeal limited insurance benefit for dementia drug choline alfoscerate

 9 July 2020 - Sixty-six manufacturers of choline alfoscerate, a dementia drug, filed an appeal to the Health Insurance Review ...

Read more →

'Xolair’s reimbursement will change treatment paradigm for asthma patients'

9 July 2020 - Novartis Korea will be able to strengthen its position in the severe allergic asthma market with ...

Read more →

So just who do we think qualifies for any COVID-19 vaccine?

 9 July 2020 - How should we allocate scarce medical resources? ...

Read more →

Access to HIV medicines severely impacted by COVID-19 as AIDS response stalls

6 July 2020 - Countries seek innovative ways to mitigate the impact of disruptions and keep services going. ...

Read more →

Canadians demand access to ‘miracle’ cystic fibrosis drug already approved in U.S. and U.K

6 July 2020 - Montreal’s Chelsea Gagnon may look like a healthy 31-year-old woman at first glance, but every single ...

Read more →

Better protection against meningococcal and pneumococcal diseases

6 July 2020 - The National Immunisation Program has been amended from 1 July 2020 to improve protection for those most ...

Read more →

Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal

5 July 2020 - Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for ...

Read more →

FDA Commissioner says he can't predict when vaccine will be ready after Trump's timeline claims

5 July 2020 - Food and Drug Administration Commissioner Stephen Hahn said Sunday that he would not make a prediction ...

Read more →

Clock ticking on Edmonton family's hope for $2.8 million drug treatment for toddler son

 3 July 2020 - Family hoping Alberta Health will pay for new drug that must be administered by mid-July. ...

Read more →

Vertex announces expansion of reimbursement agreement with NHS England to include Kaftrio (ivacaftor/tezacaftor/elexacaftor) in combination with Kalydeco (ivacaftor)

30 June 2020 - Cystic fibrosis patients in England will be among the first in Europe to benefit from access to ...

Read more →

Why States’ ‘Netflix model’ prescription drug arrangements are no silver bullet

1 July 2020 - In June 2019, Louisiana contracted with Asegua Therapeutics––a subsidiary of Gilead Sciences––to pay a lump sum ...

Read more →